WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹61 Cr | ₹58 Cr | ₹43 Cr | ₹38 Cr | ₹16 Cr |
What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹61 Cr |
Mar2024 | ₹58 Cr |
Mar2023 | ₹43 Cr |
Mar2022 | ₹38 Cr |
Mar2021 | ₹16 Cr |
How is Consolidated Net Profit of WINDLAS BIOTECH Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹61 Cr | 4.82 | |
Mar2024 | ₹58 Cr | 36.51 | |
Mar2023 | ₹43 Cr | 11.91 | |
Mar2022 | ₹38 Cr | 140.58 | |
Mar2021 | ₹16 Cr | - |
Compare Consolidated Net Profit of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹2,067.3 Cr | 7.3% | 10.1% | 35.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | 7.3% |
10.1% |
35.9% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses